US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Acceleron Pharma

178.75

0.0000

Volume:- -

Turnover:1.41B

Market Cap:10.93B

PE:-42.53

High:178.75

Open:178.75

Low:178.75

Close:178.75

52wk High:189.99

52wk Low:110.72

Shares:61.16M

Float Shares:49.90M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.2031

EPS(LYR):-2.9231

ROE:-31.59%

ROA:-18.40%

PB:15.22

PE(LYR):-61.15

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Acceleron Pharma

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.acceleronpharma.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Acceleron Pharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. It offers REBLOZYL (luspatercept-aamt), a first-in-class erythroid maturation agent, for the treatment of anemia in adult patients with beta-thalassemia and transfusion-dependent anemia. The company is also developing Sotatercept, an activin receptor type IIA fusion protein, for the treatment of patients with pulmonary arterial hypertension; ACE-1334, a pulmonary therapeutic candidate that is in Phase I clinical trials; and luspatercept-aamt for non-transfusion-dependent beta-thalassemia patients and lower-risk myelodysplastic syndrome patients. It has a license agreements with the Salk Institute for Biological Studies for the cloning of type II activin receptors; and license agreement with Fulcrum Therapeutics, Inc. to identify small molecules designed to modulate specific pathways associated with a targeted indication within the pulmonary disease space. The company was formerly known as Phoenix Pharma, Inc. Acceleron Pharma Inc. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/XLRN/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"XLRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLRN\",,,,,undefined,":{"symbol":"XLRN","market":"US","secType":"STK","nameCN":"Acceleron Pharma","latestPrice":178.75,"timestamp":1637355600000,"preClose":178.75,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":49901105,"shares":61155826,"eps":-4.203068,"marketStatus":"Halted","change":0,"latestTime":"11-19 16:00:00 EST","open":178.75,"high":178.75,"low":178.75,"amount":1407344660.7254102,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.203068,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1379563200000,"exchange":"NASDAQ","adjPreClose":178.75,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLRN\",,,,,undefined,":{"symbol":"XLRN","floatShares":49901105,"roa":"-18.40%","roe":"-31.59%","lyrEps":-2.923063,"shares":61155826,"dividePrice":0,"high":178.75,"amplitude":0,"preClose":178.75,"low":178.75,"week52Low":110.72,"pbRate":"15.22","week52High":189.99,"institutionHeld":0,"latestPrice":178.75,"eps":-4.203068,"divideRate":0,"volume":0,"delay":0,"ttmEps":-4.203068,"open":178.75,"prevYearClose":127.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLRN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-11-23","symbol":"XLRN","reason":null,"defaultRemindTime":1637677800000,"announcedDate":"2021-11-17","type":"delisting","dateTimestamp":1637643600000},{"market":"US","date":"2021-11-04","symbol":"XLRN","fiscalQuarterEnding":"2021/09","expectedEps":-1.15,"name":null,"time":"","type":"earning","dateTimestamp":1635998400000,"reportTimeType":"","actualEps":-1.14},{"market":"US","date":"2021-08-05","symbol":"XLRN","fiscalQuarterEnding":"2021/06","expectedEps":-0.92,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1628136000000,"reportTimeType":"post","actualEps":-1.05},{"market":"US","date":"2021-05-06","symbol":"XLRN","fiscalQuarterEnding":"2021/03","expectedEps":-0.83,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1620273600000,"reportTimeType":"post","actualEps":-1.03},{"market":"US","date":"2021-02-25","symbol":"XLRN","fiscalQuarterEnding":"2020/12","expectedEps":-0.66,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1614229200000,"reportTimeType":"post","actualEps":-0.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLRN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLRN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/XLRN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"XLRN","date":"2021-11-09","current":-42.528458,"percent":0.226066,"low":-64.43561,"twenty":-42.863459,"median":-26.21197,"eighty":-21.131329,"high":-16.158546,"avg":-30.861003,"sd":11.224053,"marketCap":10623378534},"quantilePoints":[{"date":"2021-02-26","current":-49.306998,"twenty":-35.770024,"median":-24.203145,"eighty":-20.500621,"marketCap":8186440870},{"date":"2021-03-05","current":-46.644172,"twenty":-36.457867,"median":-24.287759,"eighty":-20.565427,"marketCap":7744331954},{"date":"2021-03-12","current":-48.671863,"twenty":-36.806529,"median":-24.300235,"eighty":-20.662296,"marketCap":8080989387},{"date":"2021-03-19","current":-48.715626,"twenty":-37.177815,"median":-24.323107,"eighty":-20.705702,"marketCap":8088255374},{"date":"2021-03-26","current":-49.503362,"twenty":-37.428402,"median":-24.353079,"eighty":-20.814428,"marketCap":8219043154},{"date":"2021-04-01","current":-49.455952,"twenty":-37.901873,"median":-24.434061,"eighty":-20.83768,"marketCap":8211171667},{"date":"2021-04-09","current":-47.162036,"twenty":-38.274785,"median":-24.493687,"eighty":-20.843802,"marketCap":7830312809},{"date":"2021-04-16","current":-45.232812,"twenty":-38.594261,"median":-24.519025,"eighty":-20.843802,"marketCap":7510003848},{"date":"2021-04-23","current":-44.710731,"twenty":-38.754763,"median":-24.633318,"eighty":-20.843802,"marketCap":7423322717},{"date":"2021-04-30","current":-45.865972,"twenty":-38.931259,"median":-24.651602,"eighty":-20.843802,"marketCap":7615127294},{"date":"2021-05-07","current":-41.413038,"twenty":-39.134296,"median":-24.673777,"eighty":-20.885659,"marketCap":7394794821},{"date":"2021-05-14","current":-41.920738,"twenty":-39.600261,"median":-24.719081,"eighty":-20.980949,"marketCap":7485450747},{"date":"2021-05-21","current":-43.304272,"twenty":-39.830004,"median":-24.753557,"eighty":-20.98059,"marketCap":7732497330},{"date":"2021-05-28","current":-44.330874,"twenty":-40.042075,"median":-24.792338,"eighty":-20.98059,"marketCap":7915809536},{"date":"2021-06-04","current":-41.873147,"twenty":-40.180894,"median":-24.818501,"eighty":-20.98059,"marketCap":7476952831},{"date":"2021-06-11","current":-44.487244,"twenty":-40.358151,"median":-24.892581,"eighty":-20.98059,"marketCap":7943731263},{"date":"2021-06-18","current":-43.280476,"twenty":-40.496622,"median":-24.921329,"eighty":-20.98059,"marketCap":7728248371},{"date":"2021-06-25","current":-42.128098,"twenty":-40.756494,"median":-24.961191,"eighty":-20.98059,"marketCap":7522477385},{"date":"2021-07-02","current":-43.814173,"twenty":-41.006742,"median":-25.006968,"eighty":-20.982384,"marketCap":7823546439},{"date":"2021-07-09","current":-40.544002,"twenty":-41.022651,"median":-25.06987,"eighty":-20.982384,"marketCap":7239618153},{"date":"2021-07-16","current":-39.214858,"twenty":-41.022651,"median":-25.096477,"eighty":-20.982384,"marketCap":7002283476},{"date":"2021-07-23","current":-41.54341,"twenty":-41.196677,"median":-25.130378,"eighty":-20.982384,"marketCap":7418074407},{"date":"2021-07-30","current":-43.168298,"twenty":-41.401635,"median":-25.19657,"eighty":-20.982384,"marketCap":7708217567},{"date":"2021-08-06","current":-43.300872,"twenty":-41.54341,"median":-25.267224,"eighty":-20.982384,"marketCap":7731890336},{"date":"2021-08-13","current":-33.477027,"twenty":-41.54341,"median":-25.359699,"eighty":-20.982384,"marketCap":7486501046},{"date":"2021-08-20","current":-32.676389,"twenty":-41.54341,"median":-25.39242,"eighty":-20.982384,"marketCap":7307453514},{"date":"2021-08-27","current":-34.628966,"twenty":-41.558511,"median":-25.418275,"eighty":-20.981666,"marketCap":7744110250},{"date":"2021-09-03","current":-35.898005,"twenty":-41.558511,"median":-25.491873,"eighty":-20.981666,"marketCap":8027906678},{"date":"2021-09-10","current":-35.666528,"twenty":-41.558511,"median":-25.608301,"eighty":-20.981666,"marketCap":7976141235},{"date":"2021-09-17","current":-36.42904,"twenty":-41.558511,"median":-25.709131,"eighty":-20.981666,"marketCap":8146662694},{"date":"2021-09-24","current":-43.528577,"twenty":-41.757755,"median":-25.709131,"eighty":-20.981666,"marketCap":9734339276},{"date":"2021-10-01","current":-46.867293,"twenty":-41.945886,"median":-25.709131,"eighty":-20.981666,"marketCap":10480979664},{"date":"2021-10-08","current":-47.746906,"twenty":-42.205659,"median":-25.745386,"eighty":-20.981666,"marketCap":10677688346},{"date":"2021-10-15","current":-47.052217,"twenty":-42.32254,"median":-25.862109,"eighty":-20.981666,"marketCap":10522334417},{"date":"2021-10-22","current":-47.508849,"twenty":-42.46805,"median":-25.973337,"eighty":-20.981666,"marketCap":10624451447},{"date":"2021-10-29","current":-47.642831,"twenty":-42.664748,"median":-26.117458,"eighty":-21.051432,"marketCap":10654413929},{"date":"2021-11-05","current":-47.503381,"twenty":-42.863459,"median":-26.162831,"eighty":-21.10531,"marketCap":10623228489},{"date":"2021-11-09","current":-41.684501,"twenty":-42.863459,"median":-26.21197,"eighty":-21.131329,"marketCap":10623378534}],"updateTime":1771692735589},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.acceleronpharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Acceleron Pharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. It offers REBLOZYL (luspatercept-aamt), a first-in-class erythroid maturation agent, for the treatment of anemia in adult patients with beta-thalassemia and transfusion-dependent anemia. The company is also developing Sotatercept, an activin receptor type IIA fusion protein, for the treatment of patients with pulmonary arterial hypertension; ACE-1334, a pulmonary therapeutic candidate that is in Phase I clinical trials; and luspatercept-aamt for non-transfusion-dependent beta-thalassemia patients and lower-risk myelodysplastic syndrome patients. It has a license agreements with the Salk Institute for Biological Studies for the cloning of type II activin receptors; and license agreement with Fulcrum Therapeutics, Inc. to identify small molecules designed to modulate specific pathways associated with a targeted indication within the pulmonary disease space. The company was formerly known as Phoenix Pharma, Inc. Acceleron Pharma Inc. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.04143},{"month":2,"riseRate":0.75,"avgChangeRate":0.017718},{"month":3,"riseRate":0.375,"avgChangeRate":-0.033034},{"month":4,"riseRate":0.375,"avgChangeRate":-0.024899},{"month":5,"riseRate":0.625,"avgChangeRate":0.016902},{"month":6,"riseRate":0.5,"avgChangeRate":0.073116},{"month":7,"riseRate":0.375,"avgChangeRate":-0.02108},{"month":8,"riseRate":0.625,"avgChangeRate":0.041438},{"month":9,"riseRate":0.625,"avgChangeRate":0.066573},{"month":10,"riseRate":0.666667,"avgChangeRate":0.030445},{"month":11,"riseRate":0.777778,"avgChangeRate":0.090391},{"month":12,"riseRate":0.75,"avgChangeRate":0.108993}],"exchange":"NASDAQ","name":"Acceleron Pharma","nameEN":"Acceleron Pharma"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"XLRN\",market:\"US\",,,undefined,":null}}